Vulnerability of mammal communities to the combined impacts of anthropic land-use and climate change in the Himalayan conservation landscape of Bhutan

Human land-use and climate change drive biodiversity loss, precipitating the extinction crisis. The fragility of the Himalayas makes species in this landscape vulnerable to land-use and climate change. We aim to quantify the response of terrestrial mammal community to land-use and climate scenarios in the Bhutan Himalaya. Using large-scale camera-trap dataset, we examine the effects of anthropic land-use and climate variables on the terrestrial mammal assemblage using Bayesian multi-species occupancy model. Most of the terrestrial mammals in our sample displayed a strong negative relationship with anthropic land-use variables (agriculture, roads and settlement). Further, the occurrence of most species decreased with likely projections for climate variables, illustrating threats to conservation if the current trend in global warming continues. Notably, we found that biodiversity conservation in this landscape can be achieved by protecting extensive forest cover. Our findings emphasize the importance of reconciling land-use management and mammal conservation in the face of climate change and provide vital information which can be used to optimize future conservation and development plans

Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan

Bhutan has made substantial progress in reducing malaria incidence. The national guidelines recommend chloroquine (CQ) and primaquine (PQ) for radical cure of uncomplicated Plasmodium vivax, but the local efficacy has not been assessed. The impact of cases imported from India on the genetic make-up of the local vivax populations is currently unknown.Patients over 4 years of age with uncomplicated P. vivax mono-infection were enrolled into a clinical efficacy study and molecular survey. Study participants received a standard dose of CQ (25 mg/kg over 3 days) followed by weekly review until day 28. On day 28 a 14-day regimen of PQ (0.25 mg/kg/day) was commenced under direct observation. After day 42, patients were followed up monthly for a year. The primary and secondary endpoints were risk of treatment failure at day 28 and at 1 year. Parasite genotyping was undertaken at nine tandem repeat markers, and standard population genetic metrics were applied to examine population diversity and structure in infections thought to be acquired inside or outside of Bhutan.A total of 24 patients were enrolled in the clinical study between April 2013 and October 2015. Eight patients (33.3 %) were lost to follow-up in the first 6 months and another eight patients lost between 6 and 12 months. No (0/24) treatment failures occurred by day 28 and no (0/8) parasitaemia was detected following PQ treatment. Some 95.8 % (23/24) of patients were aparasitaemic by day 2. There were no haemolytic or serious events. Genotyping was undertaken on parasites from 12 autochthonous cases and 16 suspected imported cases. Diversity was high (H E 0.87 and 0.90) in both populations. There was no notable differentiation between the autochthonous and imported populations.CQ and PQ remains effective for radical cure of P. vivax in Bhutan. The genetic analyses indicate that imported infections are sustaining the local vivax population, with concomitant risk of introducing drug-resistant strains